HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michele Malagola Selected Research
Michele Malagola Research Topics
Disease
19
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 05/2002
8
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2024 - 06/2013
7
Neoplasms (Cancer)
01/2023 - 04/2005
7
Infections
12/2022 - 09/2004
6
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2024 - 08/2004
6
Hematologic Neoplasms (Hematological Malignancy)
08/2022 - 09/2004
5
Graft vs Host Disease (Graft-Versus-Host Disease)
03/2024 - 02/2013
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 04/2004
4
Residual Neoplasm
08/2023 - 08/2014
4
Leukemia
09/2022 - 12/2019
4
Hodgkin Disease (Hodgkin's Disease)
11/2020 - 05/2010
3
Malnutrition (Nutritional Deficiencies)
12/2023 - 01/2020
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2022 - 10/2014
3
Multiple Myeloma
10/2014 - 04/2005
2
Hematologic Diseases (Blood Diseases)
10/2022 - 12/2019
2
Primary Myelofibrosis (Myelosclerosis)
01/2022 - 10/2021
2
Mycoses (Diseases, Fungus)
01/2022 - 11/2008
2
Neutropenia
01/2022 - 09/2004
2
Philadelphia Chromosome
12/2019 - 04/2016
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2014 - 04/2005
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2024
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023
1
Pneumonia (Pneumonitis)
12/2023
1
Cytopenia
01/2023
1
Disease Progression
01/2023
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2019
1
Bronchiolitis Obliterans Syndrome
12/2016
1
Aplastic Anemia (Anemia, Hypoplastic)
10/2014
1
Immunoglobulin Light-chain Amyloidosis
09/2008
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
09/2008
1
Paraproteinemias (Monoclonal Gammopathy)
09/2008
1
Pathologic Complete Response
10/2005
1
Thrombocytopenia (Thrombopenia)
09/2004
1
Myeloid Sarcoma (Chloroma)
09/2004
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
08/2004
1
Aspergillosis
03/2004
Drug/Important Bio-Agent (IBA)
7
Tyrosine Kinase Inhibitors
IBA
01/2024 - 09/2013
7
Imatinib Mesylate (Gleevec)
FDA Link
04/2016 - 02/2004
5
fludarabine
IBA
07/2010 - 04/2005
5
Cytarabine (Cytosar-U)
FDA Link
Generic
10/2009 - 07/2004
3
letermovir
IBA
01/2022 - 01/2020
3
Idarubicin (4 Demethoxydaunorubicin)
FDA Link
Generic
10/2009 - 11/2008
3
Etoposide (VP 16)
FDA Link
Generic
10/2009 - 10/2005
2
Transforming Growth Factor beta (TGF-beta)
IBA
12/2023 - 08/2022
2
Chimeric Antigen Receptors
IBA
01/2023 - 10/2022
2
Biomarkers (Surrogate Marker)
IBA
09/2022 - 01/2020
2
idelalisib
IBA
02/2022 - 01/2021
2
liposomal amphotericin B
FDA Link
01/2022 - 03/2004
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 01/2020
2
Azacitidine (5 Azacytidine)
FDA Link
11/2015 - 06/2013
2
Gemtuzumab (Mylotarg)
FDA Link
12/2008 - 09/2004
2
Thalidomide (Thalomid)
FDA Link
09/2008 - 04/2005
1
Lactose
FDA Link
Generic
03/2024
1
RNA (Ribonucleic Acid)
IBA
08/2023
1
Busulfan (Busulfex)
FDA Link
03/2023
1
treosulfan
IBA
03/2023
1
Alkylating Agents
IBA
03/2023
1
Tumor Biomarkers (Tumor Markers)
IBA
09/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
posaconazole
FDA Link
01/2022
1
daratumumab
IBA
01/2022
1
Fluoroquinolones
IBA
01/2022
1
carbapenemase
IBA
01/2022
1
Phosphotransferases (Kinase)
IBA
12/2019
1
thymoglobulin
FDA Link
11/2018
1
Dasatinib (BMS 354825)
FDA Link
04/2016
1
Brentuximab Vedotin
IBA
03/2015
1
Steroids
IBA
10/2014
1
Erythropoietin
FDA Link
06/2013
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
02/2013
1
Proteins (Proteins, Gene)
FDA Link
07/2010
1
HLA Antigens (Human Leukocyte Antigens)
IBA
05/2010
1
Cytosine
IBA
11/2008
1
Melphalan (Alkeran)
FDA Link
Generic
09/2008
1
Lenalidomide (CC 5013)
FDA Link
09/2008
1
Prednisone (Sone)
FDA Link
Generic
09/2008
1
Bortezomib (Velcade)
FDA Link
09/2008
1
Mitoxantrone (Novantrone)
FDA Link
Generic
10/2005
1
Bilirubin
IBA
09/2004
1
Calicheamicins
IBA
09/2004
1
Transaminases (Aminotransferases)
IBA
09/2004
1
Core Binding Factors (Core-Binding Factor)
IBA
07/2004
1
Alemtuzumab (Campath)
FDA Link
04/2004
Therapy/Procedure
18
Stem Cell Transplantation
03/2024 - 04/2004
12
Therapeutics
03/2024 - 07/2004
7
Hematopoietic Stem Cell Transplantation
03/2024 - 10/2014
7
Drug Therapy (Chemotherapy)
01/2023 - 08/2003
5
Transplantation
12/2023 - 04/2005
3
Cell Transplantation
04/2024 - 01/2017
2
Nutritional Support (Artificial Feeding)
12/2023 - 08/2022
2
Induction Chemotherapy
10/2009 - 11/2008
1
Enteral Nutrition (Feeding, Tube)
12/2023
1
Immunotherapy
01/2023
1
Radiotherapy
01/2023
1
Lasers (Laser)
10/2021
1
Haploidentical Transplantation
11/2020
1
Photopheresis
12/2016
1
Consolidation Chemotherapy
08/2014
1
Homologous Transplantation
05/2010
1
Autologous Transplantation
05/2010